Security
IRIDEX Corporation Common Stock · IRIX
IRIXNASDAQCommon stockCurrentCIK 1006045Updated Oct 14, 2026
IRIX price & chart
Loading TradingView…
NASDAQ:IRIX on TradingView ↗About the company
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, which include capital equipment and consumable probes for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers the therapeutic benefits of laser treatment while minimizing tissue damage, offering a safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.
In the news
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 ↗
Recent filings
4 filing
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Submission of Matters to a Vote of Security Holders · Regulation FD Disclosure
Items 5.07, 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 28,353,000Source | 30,154,000Source | 27,258,000Source | 31,585,000Source | 31,249,000Source | 28,274,000Source | 34,236,000Source | 34,092,000Source | 29,151,000Source | 29,135,000Source | 34,436,000Source | 42,290,000Source |
| Property, Plant and Equipment, NetUSD | 23,000Source | 157,000Source | 182,000Source | 40,000Source | 209,000Source | 139,000Source | 75,000Source | 265,000Source | 58,000Source | 115,000Source | 351,000Source | 462,000Source |
| GoodwillUSD | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,573,000Source | 3,860,000Source | 4,680,000Source | 6,778,000Source | 4,111,000Source | 4,595,000Source | 7,244,000Source | 5,419,000Source | 6,028,000Source | 2,387,000Source | 7,034,000Source | 13,922,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 7,132,000Source | 5,954,000Source | 5,674,000Source | 7,137,000Source | 6,269,000Source | 6,844,000Source | 6,680,000Source | 6,525,000Source | 7,613,000Source | 5,951,000Source | 6,727,000Source | 6,229,000Source |
| Inventory, NetUSD | 7,301,000Source | 10,942,000Source | 9,752,000Source | 8,435,000Source | 11,124,000Source | 9,325,000Source | 10,142,000Source | 11,003,000Source | 7,877,000Source | 10,817,000Source | 9,906,000Source | 10,608,000Source |
| Assets, CurrentUSD | 24,066,000Source | 24,337,000Source | 23,958,000Source | 26,868,000Source | 25,007,000Source | 24,584,000Source | 29,129,000Source | 27,578,000Source | 25,252,000Source | 23,562,000Source | 27,450,000Source | 35,766,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,662,000Source | 1,755,000Source | 2,437,000Source | 1,625,000Source | 1,730,000Source | 2,248,000Source | 2,357,000Source | 2,010,000Source | 1,802,000Source | 1,964,000Source | 856,000Source | 1,468,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,039,000Source | 2,034,000Source | 220,000Source | 1,295,000Source | 2,172,000Source | 496,000Source | 1,546,000Source | 2,402,000Source | 768,000Source | 1,792,000Source | 2,632,000Source | 1,665,000Source |
| Other Assets, NoncurrentUSD | 1,196,000Source | 1,270,000Source | 1,108,000Source | 1,273,000Source | 1,421,000Source | 1,186,000Source | 1,298,000Source | 1,324,000Source | 1,124,000Source | 1,394,000Source | 1,396,000Source | 1,455,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 23,672,000Source | 27,531,000Source | 23,619,000Source | 25,526,000Source | 27,003,000Source | 23,542,000Source | 27,384,000Source | 27,604,000Source | 24,229,000Source | 27,038,000Source | 24,914,000Source | 25,059,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | — | — | 0Source | — | — | 0Source | — | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 174,000Source | 174,000Source | 174,000Source | 174,000Source | 172,000Source | 174,000Source | 174,000Source | 172,000Source | 174,000Source | 174,000Source | 172,000Source | 169,000Source |
| Retained Earnings (Accumulated Deficit)USD | -92,262,000Source | -87,118,000Source | -94,236,000Source | -90,689,000Source | -85,185,000Source | -92,970,000Source | -89,695,000Source | -82,506,000Source | -92,446,000Source | -88,009,000Source | -79,042,000Source | -69,716,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -13,000Source | 2,000Source | -11,000Source | -13,000Source | 2,000Source | -10,000Source | 29,000Source | -16,000Source | -14,000Source | 51,000Source | -52,000Source | -24,000Source |
| Stockholders' Equity Attributable to ParentUSD | 4,681,000Source | 2,623,000Source | 3,639,000Source | 6,059,000Source | 4,246,000Source | 4,732,000Source | 852,000Source | 6,488,000Source | 4,922,000Source | 2,097,000Source | 9,522,000Source | 17,231,000Source |
| Additional Paid in Capital, Common StockUSD | 90,782,000Source | 89,565,000Source | 91,712,000Source | 90,587,000Source | 89,257,000Source | 91,538,000Source | 90,344,000Source | 88,838,000Source | 91,208,000Source | 89,881,000Source | 88,444,000Source | 86,802,000Source |
| Liabilities and EquityUSD | 28,353,000Source | 30,154,000Source | 27,258,000Source | 31,585,000Source | 31,249,000Source | 28,274,000Source | 34,236,000Source | 34,092,000Source | 29,151,000Source | 29,135,000Source | 34,436,000Source | 42,290,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 12,392,000Source | 15,852,000Source | 13,173,000Source | 13,709,000Source | 16,145,000Source | 12,828,000Source | 14,947,000Source | 16,066,000Source | 13,208,000Source | 16,559,000Source | 12,974,000Source | 12,453,000Source |
| Operating Lease, Liability, CurrentUSD | 1,028,000Source | 995,000Source | 141,000Source | 1,145,000Source | 995,000Source | 424,000Source | 1,120,000Source | 995,000Source | 699,000Source | 1,094,000Source | 995,000Source | 1,037,000Source |
| Accounts Payable, CurrentUSD | 4,409,000Source | 6,201,000Source | 6,650,000Source | 5,314,000Source | 7,767,000Source | 5,753,000Source | 6,048,000Source | 7,681,000Source | 5,385,000Source | 6,985,000Source | 4,499,000Source | 3,858,000Source |
| Operating Lease, Liability, NoncurrentUSD | 52,000Source | 1,155,000Source | 77,000Source | 248,000Source | 1,294,000Source | 87,000Source | 535,000Source | 1,526,000Source | 98,000Source | 811,000Source | 1,751,000Source | 732,000Source |
| Other Liabilities, NoncurrentUSD | 315,000Source | 321,000Source | 496,000Source | 307,000Source | 303,000Source | 440,000Source | 290,000Source | 304,000Source | 387,000Source | 314,000Source | 26,000Source | 26,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 592,000Source | 1,007,000Source | 760,000Source | 584,000Source | 868,000Source | 692,000Source | 969,000Source | 1,112,000Source | 608,000Source | 477,000Source | 1,996,000Source | 1,548,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 30,000Source | 29,000Source | 26,000Source | 24,000Source |
| Long-term DebtUSD | — | 1,400,000Source | — | — | — | — | — | — | — | 1,000,000Source | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -524,000Source | -1,686,000Source | -4,437,000Source | -8,910,000Source | -9,570,000Source | -7,547,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -769,000Source | 729,000Source | 1,662,000Source | -776,000Source | 254,000Source | -196,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 1,448,000Source | -675,000Source | -2,117,000Source | 911,000Source | -644,000Source | 3,019,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 368,000Source | -1,291,000Source | -1,954,000Source | 2,486,000Source | 641,000Source | 1,086,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,335,000Source | -1,149,000Source | -2,115,000Source | -7,285,000Source | -6,745,000Source | -9,519,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -101,000Source | -11,000Source | -143,000Source | -13,000Source | -109,000Source | -286,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 101,000Source | 11,000Source | 143,000Source | 13,000Source | 109,000Source | 286,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 1,000Source | 0Source | 75,000Source | 58,000Source | 87,000Source | 94,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,000Source | 6,039,000Source | 5,964,000Source | 2,605,000Source | -5,000Source | -73,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,433,000Source | 4,857,000Source | 3,641,000Source | -4,647,000Source | -6,888,000Source | -9,930,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 0Source | 24,000Source | -22,000Source | 15,000Source | 53,000Source | 73,000Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | 57,000Source | 57,000Source | 200,000Source | 200,000Source | 200,000Source | 0Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 92,000Source | 114,000Source | 212,000Source | 257,000Source | 211,000Source | 213,000Source | 775,000Source | 1,243,000Source | 1,650,000Source | 1,621,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | 30,000Source | 78,000Source | 169,000Source | 182,000Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | 700,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 80,000Source | 84,000Source | 323,000Source | 333,000Source | 333,000Source | 228,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 200,000Source | 244,000Source | 277,000Source | 257,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | 0Source | -1,335,000Source | -1,335,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 1,795,000Source | 2,248,000Source | 1,842,000Source | 2,216,000Source | 1,623,000Source | 1,931,000Source | 7,734,000Source | 9,776,000Source | 8,748,000Source | 7,557,000Source |
| GoodwillUSD | — | — | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source | 965,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 4,000Source | 17,000Source | 70,000Source | 21,000Source | 58,000Source | 12,000Source | 57,000Source | 68,000Source | 90,000Source | 65,000Source |
| Inventory Write-downUSD | — | — | 800,000Source | — | — | — | — | — | 823,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,573,000Source | -1,933,000Source | -1,266,000Source | -994,000Source | -524,000Source | -1,686,000Source | -4,437,000Source | -8,910,000Source | -9,570,000Source | -7,547,000Source |
| Nonoperating Income (Expense)USD | — | — | -158,000Source | -46,000Source | -167,000Source | -33,000Source | -142,000Source | -1,469,000Source | -1,809,000Source | -540,000Source | 527,000Source | 60,000Source |
| Operating ExpensesUSD | — | — | 5,424,000Source | 6,193,000Source | 5,325,000Source | 5,622,000Source | 5,065,000Source | 5,260,000Source | 21,798,000Source | 27,804,000Source | 31,814,000Source | 32,910,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 300,000Source | 300,000Source | 1,100,000Source | 1,100,000Source | 1,000,000Source | 1,000,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 0Source | 4,000Source | 82,000Source | 21,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 12,484,000Source | 11,581,000Source | 12,566,000Source | 13,571,000Source | 11,799,000Source | 11,896,000Source | 52,675,000Source | 48,669,000Source | 51,869,000Source | 56,972,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | -1,411,000Source | -1,870,000Source | -1,029,000Source | -940,000Source | -324,000Source | -205,000Source | -2,571,000Source | -8,302,000Source | -10,007,000Source | -7,542,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,569,000Source | -1,916,000Source | -1,196,000Source | -973,000Source | -466,000Source | -1,674,000Source | -4,380,000Source | -8,842,000Source | -9,480,000Source | -7,482,000Source |
| Income Tax Expense (Benefit)USD | — | — | 4,000Source | 17,000Source | 70,000Source | 21,000Source | 58,000Source | 12,000Source | 57,000Source | 68,000Source | 90,000Source | 65,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,573,000Source | -1,933,000Source | -1,266,000Source | -994,000Source | -524,000Source | -1,686,000Source | -4,437,000Source | -8,910,000Source | -9,570,000Source | -7,547,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.09Source | -0.12Source | -0.07Source | -0.06Source | -0.03Source | -0.1Source | -0.26Source | -0.54Source | -0.59Source | -0.47Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.09Source | -0.12Source | -0.07Source | -0.06Source | -0.03Source | -0.1Source | -0.26Source | -0.54Source | -0.59Source | -0.47Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 17,009,000Source | 16,581,000Source | 17,418,000Source | 16,793,000Source | 17,311,000Source | 16,727,000Source | 16,934,000Source | 16,439,000Source | 16,128,000Source | 15,938,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 17,009,000Source | 16,581,000Source | 17,418,000Source | 16,793,000Source | 17,311,000Source | 16,727,000Source | 16,934,000Source | 16,439,000Source | 16,128,000Source | 15,938,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 80,000Source | 84,000Source | 323,000Source | 333,000Source | 333,000Source | 228,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 56,000Source | 65,000Source | 89,000Source | 65,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 100,000Source | 135,000Source | 523,000Source | 584,000Source | 1,098,000Source | 485,000Source |
| General and Administrative ExpenseUSD | — | — | 1,795,000Source | 2,248,000Source | 1,842,000Source | 2,216,000Source | 1,623,000Source | 1,931,000Source | 7,734,000Source | 9,776,000Source | 8,748,000Source | 7,557,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 4,013,000Source | 4,323,000Source | 4,296,000Source | 4,682,000Source | 4,741,000Source | 5,055,000Source | 19,227,000Source | 19,502,000Source | 21,807,000Source | 25,368,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -5,050,000Source | -8,679,000Source | -9,673,000Source | -7,544,000Source |
| Interest Expense, DebtUSD | — | — | — | 58,000Source | — | — | — | — | 58,000Source | 146,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | -158,000Source | -46,000Source | -167,000Source | -33,000Source | -142,000Source | -1,469,000Source | -1,809,000Source | -540,000Source | 527,000Source | 60,000Source |
| Operating ExpensesUSD | — | — | 5,424,000Source | 6,193,000Source | 5,325,000Source | 5,622,000Source | 5,065,000Source | 5,260,000Source | 21,798,000Source | 27,804,000Source | 31,814,000Source | 32,910,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 300,000Source | 300,000Source | 1,100,000Source | 1,100,000Source | 1,000,000Source | 1,000,000Source |
| Research and Development ExpenseUSD | — | — | 972,000Source | 1,299,000Source | 936,000Source | 871,000Source | 905,000Source | 876,000Source | 3,668,000Source | 5,449,000Source | 6,829,000Source | 7,175,000Source |
| Selling and Marketing ExpenseUSD | — | — | 2,657,000Source | 2,646,000Source | 2,547,000Source | 2,535,000Source | 2,537,000Source | 2,453,000Source | 10,396,000Source | 12,579,000Source | 16,237,000Source | 18,178,000Source |
Filing attachments
irix-ex99_1.htm · 8-K · 2026-08-18
EX-99.1 2 irix-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Iridex Reports Second Quarter 2026 Financial Results MOUNTAIN VIEW, Calif., August 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 4, 2026. Second Quarter 2026 Financial Highlights • G…
Read attachment ↗d101758dex991.htm · 8-K · 2026-07-16
EX-99.1 2 d101758dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 3 July 2026 David Lin Novel Inspiration International Co., Ltd David, This letter was drafted to comply with a recent resolution of the current board of directors (the “Board”) of Iridex Corporation (“Iridex” or the “Company”). Its purpose is to attempt to engage with Novel Inspiration (“Novel”) in pursuit of greater clarity, in both directions, as to why, and as to how, the Company’s largest stockholder has positioned itself adverse …
Read attachment ↗irix-ex99_1.htm · 8-K · 2026-05-19
EX-99.1 2 irix-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Iridex Reports First Quarter 2026 Financial Results 2026 Guidance Affirmed MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the first quarter ended April 4, 2026. First Quarter 2026 F…
Read attachment ↗irix-ex99_1.htm · 8-K · 2026-03-26
EX-99.1 2 irix-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Iridex Reports Fourth Quarter and Full Year 2025 Financial Results Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, toda…
Read attachment ↗irix-ex99_1.htm · 8-K · 2026-01-12
EX-99.1 2 irix-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 Demonstrating continued revenue growth, operational efficiencies and positive cash flow MOUNTAIN VIEW, Calif., Jan. 12, 2026 - Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, …
Read attachment ↗